DUSP3 and cervical cancer: Finally, because VHR is regulated during cell cycle progression and because its suppression by RNAi[3] halts cellular proliferation and induces cellular senescence, and, more importantly, because of its overexpression in the cervix cancer, we propose that VHR may be a good target for anticancer therapy.